🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPharmacology & MechanismsGLP-1/GIP receptor co-agonism — September 2026 Page 3

GLP-1/GIP receptor co-agonism — September 2026

AussieAnna Thu, Aug 29, 2024 at 11:51 PM 11 replies 1,876 viewsPage 3 of 3
BariatricNurseD
Senior Member
1,678
7,234
Feb 2024
Dallas, TX
Online
Sep 1, 2024 at 7:31 PM#11
claudia_zurich said:
The mechanism is more central than most summaries suggest.

Agreed, and the adaptation point cuts both ways: tachyphylaxis to gastric emptying is why tolerability improves, and it is also why people who were relying on physical fullness feel the effect fade while the appetite effect is still working.

39 12tony_orlando, Dr.NephBHM_UK, kim_atl_prep and 36 others
Reply Quote Save Share Report
paul_denver
Member
723
3,234
May 2024
Denver, CO
Sep 2, 2024 at 9:42 PM#12
dave_SLC said:
Agreed on the mechanism, with the caveat that the head-to-head used semaglutide 1mg, not 2.4mg.

This answered a question I did not know how to ask.

40 13jason_paloalto, Dr.LeslieOBGYN, MikeNYC_runner and 37 others
Reply Quote Save Share Report
SarahChen_PharmD
VIP Member
4,567
22,341
Dec 2023
San Diego, CA
Sep 3, 2024 at 11:52 PM#13
claudia_zurich said:
The mechanism is more central than most summaries suggest.

Careful with the causal language. Two things moving together in a period when five things changed is not a mechanism, and stating it as one makes the thread less useful to somebody reading it later.

41 14paul_denver, TinaHashiRN, robert_kc and 38 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.PeteFamMed
Senior Member
2,012
9,234
Jan 2024
Minneapolis, MN
Sep 5, 2024 at 2:02 AM#14

The figures, for anyone assembling their own picture. If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way. Most of the apparent contradictions in these threads dissolve at that step.

Worth separating that from the pharmacology, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

Last edited: Sep 5, 2024 at 3:02 AM
42 15Dr.BariatricHTX, LindaRN_retired, tommy_boulder and 39 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Sep 6, 2024 at 4:11 AM#15

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. Thread quality here is what the rules are for. Keep it up.

43 16PurityPaulOR, MaxMetOK, MounjBrad and 40 others
Reply Quote Save Share Report

Similar Threads

GLP-1R desensitization — β-arrestin-mediated internalization18 replies
Biased agonism at GLP-1R — Gs vs β-arrestin signaling balance13 replies
Semaglutide albumin binding and the C-18 fatty acid linker17 replies
GIP receptor pharmacology — why GIP agonism enhances GLP-113 replies
Glucagon receptor signaling — hepatic glycogenolysis and lipolysis16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register